(Q46412218)

English

Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advance

scientific article published on 26 August 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advance (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

2

object named as

Waun Ki Hong

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

author name string

Michael B Sporn

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

publication date

26 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

Nature Clinical Practice Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

628-629

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

Clinical prevention of recurrence of colorectal adenomas by the combination of difluoromethylornithine and sulindac: an important milestone

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

based on heuristic

inferred from DOI database lookup

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advances in chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NCPONC1221

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18725921

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46412218&oldid=2109943002"